Item 1.01 | Entry into a Material Definitive Agreement. |
On February 14, 2025 (the “Funding Date”), APi Group DE, Inc. (the “Borrower”), a wholly owned subsidiary of APi Group Corporation (the “Company”), entered into and closed the transactions contemplated by that certain Amendment No. 7 to Credit Agreement (“Amendment No. 7”), by and among the Borrower, the Company, as a guarantor, certain subsidiaries of the Borrower party thereto, as guarantors, and Citibank, N.A., as collateral agent and as administrative agent (in such collective capacities, the “Agent”), and the lenders party thereto, which amends that certain Credit Agreement, dated as of October 1, 2019, as amended by Amendment No. 1 to Credit Agreement, dated as of October 22, 2020, Amendment No. 2 to Credit Agreement, dated as of December 16, 2021, Amendment No. 3 to Credit Agreement, dated as of May 19, 2023, Amendment No. 4 to Credit Agreement, dated as of October 11, 2023, Amendment No. 5 to Credit Agreement, dated as of February 28, 2024, and Amendment No. 6 to Credit Agreement, dated as of May 10, 2024, by and among the Borrower, the Company, the subsidiary guarantors from time to time party thereto, the lenders and letter of credit issuers from time to time party thereto, and the Agent (as amended, supplemented or modified from time to time, the “Existing Credit Agreement” and the Existing Credit Agreement as amended by Amendment No. 7, the “Credit Agreement”).
Amendment No. 7 provides for the refinancing of the existing incremental term loans, denominated in U.S. dollars (the “Existing 2021 Incremental Term Loans”), in full by borrowing principal amounts under the Credit Agreement of approximately $2,157 million (the “Repriced 2021 Incremental Term Loans”), to pay off the outstanding incremental term loans maturing January 3, 2029 under the Existing Credit Agreement on the Funding Date. Therefore, on the Funding Date, after giving effect to the refinancing heretofore described, the outstanding principal balance of the Repriced 2021 Incremental Term Loans was approximately $2,157 million.
The maturity date of the Repriced 2021 Incremental Term Loans is January 3, 2029, which is the same maturity date as the Existing 2021 Incremental Term Loans that were paid off in full on the Funding Date.
Pursuant to Amendment No. 7, the interest rate applicable to the Repriced 2021 Incremental Term Loans, at the Borrower’s option, are either (1) a base rate, plus a reduced applicable margin, equal to 0.75% per annum or (2) a Term SOFR rate (adjusted for statutory reserves), plus a reduced applicable margin, equal to 1.75% per annum. The Company’s aggregate $1,840 million of interest rate swaps related to its term loans will remain in effect following this refinancing.
Except as set forth in Amendment No. 7 and as described above, the Repriced 2021 Incremental Term Loans have identical terms to the Existing 2021 Incremental Term Loans as set forth in, and otherwise subject to the provisions of, the Credit Agreement.
The foregoing description of Amendment No. 7 does not purport to be complete and is subject to, and qualified in its entirety by, the full text of Amendment No. 7, a copy of which is filed herewith as Exhibit 10.1 and is incorporated herein by reference.
Item 2.02 | Results of Operations and Financial Condition. |
On February 19, 2025, the Company issued a press release to announce, among other things, its preliminary unaudited financial results for the year ended 2024, a copy of which is furnished herewith as Exhibit 99.1.
Item 2.03 | Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. |
The information set forth under Item 1.01 of this Current Report on Form 8-K is hereby incorporated in this Item 2.03 by reference.
Item 7.01 | Regulation FD Disclosure. |
On February 19, 2025, the Company issued a press release to announce, among other things, its preliminary financial guidance for 2025 and the closing of the transactions contemplated by Amendment No. 7, a copy of which is furnished herewith as Exhibit 99.1.
The information furnished under Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.